Xopenex Overview
- Status
-
Acquired/Merged
- Latest Deal Type
-
M&A
- Financing Rounds
-
1
Xopenex General Information
Description
Provider of healthcare services. The company manufactures a pharmaceutical under the Xopenex brand which is used in the treatment and prevention of bronchospasm in adults, adolescents and children.
Contact Information
Ownership Status
Acquired/Merged
Financing Status
Corporate Backed or Acquired
Primary Industry
Pharmaceuticals
Acquirer
Primary Office
- 84 Waterford Drive
- Marlborough, MA 01752
- United States
Xopenex Valuation & Funding
| Deal Type | Date | Amount | Valuation/ EBITDA |
Post-Val | Status | Debt |
|---|
Xopenex Former Investors
| Investor Name | Investor Type | Holding | Investor Since | Participating Rounds | Contact Info |
|---|